ASTRAZEN Intraday Analysis...

ASTRAZEN Share Price

Open 1383.70 Change Price %
High 1498.00 1 Day 124.25 9.20
Low 1381.20 1 Week 165.05 12.61
Close 1474.25 1 Month 329.30 28.76
Volume 508103 1 Year 557.70 60.85
52 Week High 1514.90
52 Week Low 880.20
ASTRAZEN Important Levels
Resistance 2 1582.52
Resistance 1 1537.91
Pivot 1451.15
Support 1 1410.59
Support 2 1365.98
NSE INDIA Most Active Stocks
RCOM 14.70 -1.34%
JPASSOCIAT 17.25 2.37%
IDBI 58.90 1.99%
PNB 81.90 -1.80%
SUZLON 7.70 0.65%
IDFCBANK 42.05 -1.06%
SBIN 273.05 1.64%
ICICIBANK 300.65 0.91%
BANKBARODA 121.50 -0.41%
ITC 265.15 1.65%
More..
NSE INDIA Top Gainers Stocks
RAJRAYON 0.25 25.00%
CELESTIAL 13.85 19.91%
ADSL 19.55 18.48%
NDGL 1446.45 16.77%
SUJANAUNI 0.55 10.00%
WEIZFOREX 530.50 9.99%
ELAND 8.95 9.82%
TREEHOUSE 10.75 9.69%
ASTRAZEN 1474.25 9.20%
FMGOETZE 446.00 8.74%
More..
NSE INDIA Top Losers Stocks
HIKAL 157.60 -31.82%
UVSL 0.15 -25.00%
MVL 0.25 -16.67%
MVL 0.25 -16.67%
SOMICONVEY 48.40 -11.68%
DUCON 21.95 -11.31%
METKORE 2.00 -9.09%
BIGBLOC 133.50 -7.74%
ZENITHBIR 0.60 -7.69%
RENUKA 13.45 -6.60%
More..

AstraZeneca Pharma India Limited (NSE: ASTRAZEN)

ASTRAZEN Technical Analysis 5
As on 22nd Jun 2018 ASTRAZEN Share Price closed @ 1474.25 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1056.30 & Strong Buy for SHORT-TERM with Stoploss of 1138.96 we also expect STOCK to react on Following IMPORTANT LEVELS.
ASTRAZEN Target for June
1st Target up-side 1305.15
2nd Target up-side 1385.37
3rd Target up-side 1465.59
1st Target down-side 1076.25
2nd Target down-side 996.03
3rd Target down-side 915.81
ASTRAZEN Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is Above 70 Over Bought
MFI (14) MFI is Above 80 Over Bought
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is Above -20 Over Bought
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 1210.46
10 Day Avg Volume Traded 114.74 % More then 10 Day Average Volume
ASTRAZEN Other Details
Segment EQ
Market Capital 1830661632.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.astrazenecaindia.com
ASTRAZEN Address
ASTRAZEN
Avishkar
Post box No. 2483
Bengaluru, 560024
India
Phone: 91 80 6774 8000
Fax: 91 80 2362 2015
ASTRAZEN Latest News
AstraZeneca Pharma India Limited   Moneycontrol.com   - 06th Feb 15
Update for AstraZeneca Pharma India Ltd   Hindu Business Line   - 27th Nov 14
Bombay High Court stays delisting proposal of AstraZeneca Pharma   pharmabiz.com   - 10th Oct 14
HC stays proposed delisting of AstraZeneca Pharma   Livemint   - 09th Oct 14
AstraZeneca delisting plan faces opposition   Livemint   - 14th Jul 14
Astrazeneca Pharma India falls; SEBI says exchanges to monitor delisting   Reuters   - 25th Jun 14
Delisting: Will AstraZeneca be third time lucky?   Hindu Business Line   - 20th Mar 14
AstraZeneca Pharma India board approves delisting offer   VC Circle   - 18th Mar 14
Astrazeneca Pharma India surges on delisting proposal   Reuters   - 03rd Mar 14
AstraZeneca Pharma promoter to sell stake in Indian arm   Economic Times   - 24th May 13
Interactive Technical Analysis Chart AstraZeneca Pharma India Limited ( ASTRAZEN NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on AstraZeneca Pharma India Limited
ASTRAZEN Business Profile
AstraZeneca is in the Pharmaceuticals sector. AstraZeneca plc is a British-Swedish multinational pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world's seventh-largest pharmaceutical company measured by 2009 prescription drug sales (after Pfizer, Novartis, Sanofi, and GlaxoSmithKline) and has operations in over 100 countries.It has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. The company was founded in 1999 through the merger of the Sweden-based Astra AB and the UK-based Zeneca Group. AstraZeneca has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It had a market capitalisation of approximately £39.5 billion as of 23 December 2011, the tenth-largest of any company with a primary listing on the London Stock Exchange.[7] It has secondary listings on the New York Stock Exchange and the OMX exchange. The current market capitalisation stands at Rs 2,061.75 crore.The company has reported a standalone sales of Rs 115.66 crore and a Net Loss of Rs 1.23 crore for the quarter ended Sep 2013. The company management includes D E Udwadia - Chairman, Sanjay Murdeshwar - Managing Director, Robert Ian Haxton - Whole Time Director, Narayan K Seshadri - Director, Ian Brimicombe - Director. It is listed on the BSE with a BSE Code of 506820 and the NSE with an NSE Code of ASTRAZEN. Its Registered office is at "Avishkar", Off Bellary Road,,Hebbal. Bangalore,Karnataka - 560024.